Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Helsinn Healthcare vs. Teva Pharmaceuticals on Aloxi® patent for the US market Lugano, Switzerland, and Woodcliff Lake, N.J., May 2, 2017 - A panel of The United States Court of Appeals for the...
-
Helsinn Advanced Synthesis wins across all categories at 2017 CMO Leadership Awards Consistent strong performance sees Helsinn Advanced Synthesis SA win six awards for the third consecutive...
-
Helsinn Collaborates with Lyfebulb to Support Patient-Driven Innovations for People with Cancer Lugano, Switzerland and New York, NY, March 21, 2017 - Helsinn, a Swiss pharmaceutical group...
-
Helsinn Provides Grant for ESMO's Preceptorship Course on Supportive and Palliative Care Lugano, Switzerland, February 15, 2017 - Helsinn, a Swiss pharmaceutical group focused on building quality...
-
Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia Anti-emetic products...
-
Helsinn Group Launches "Helsinn Cares" Patient Support Services in the US Patient Assistance Program and Voucher Program will support both insured and uninsured patients in the United States...